Gross, G <br/><br/>
Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial.  [electronic resource] 

 -  Genitourinary medicine  Feb 1996 
 - 71 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Letter; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0266-4348 
<br/><br/><label>Standard No.: </label>10.1136/sti.72.1.71  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antiviral Agents--therapeutic use<br/>Combined Modality Therapy<br/>Condylomata Acuminata--prevention & control<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Laser Therapy--methods<br/>Male<br/>Middle Aged<br/>Recombinant Proteins<br/>Recurrence